Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
AMGN [NASD]
Amgen Inc.
IndexS&P 500 P/E20.37 EPS (ttm)6.53 Insider Own0.10% Shs Outstand759.61M Perf Week5.30%
Market Cap101.04B Forward P/E14.83 EPS next Y8.97 Insider Trans24.61% Shs Float758.77M Perf Month12.29%
Income5.01B PEG2.09 EPS next Q2.10 Inst Own81.50% Short Float1.26% Perf Quarter19.11%
Sales19.46B P/S5.19 EPS this Y20.30% Inst Trans-1.10% Short Ratio3.19 Perf Half Y8.95%
Book/sh32.12 P/B4.14 EPS next Y6.77% ROA7.70% Target Price140.15 Perf Year29.84%
Cash/sh34.48 P/C3.86 EPS next 5Y9.72% ROE22.00% 52W Range101.87 - 133.98 Perf YTD18.41%
Dividend2.44 P/FCF21.69 EPS past 5Y12.00% ROI10.50% 52W High-1.12% Beta0.52
Dividend %1.83% Quick Ratio4.00 Sales past 5Y4.50% Gross Margin80.50% 52W Low30.04% ATR2.63
Employees20000 Current Ratio4.40 Sales Q/Q10.70% Oper. Margin33.80% RSI (14)68.63 Volatility2.51% 1.84%
OptionableYes Debt/Eq1.37 EPS Q/Q21.80% Profit Margin25.70% Rel Volume0.52 Prev Close133.02
ShortableYes LT Debt/Eq1.26 EarningsJul 29 AMC Payout32.60% Avg Volume2.99M Price132.48
Recom2.20 SMA204.49% SMA509.01% SMA20012.96% Volume693,093 Change-0.41%
04-Aug-14Reiterated Argus Buy $135 → $140
30-Jul-14Reiterated RBC Capital Mkts Outperform $125 → $138
18-Jul-14Reiterated Deutsche Bank Buy $144 → $149
23-Apr-14Reiterated Oppenheimer Perform $121 → $122
21-Mar-14Reiterated Barclays Equal Weight $115 → $130
31-Jan-14Reiterated Argus Buy $130 → $135
20-Nov-13Reiterated Deutsche Bank Buy $138 → $142
29-Aug-13Reiterated UBS Buy $121 → $124
27-Aug-13Reiterated Barclays Overweight $105 → $115
31-Jul-13Reiterated Oppenheimer Perform $100 → $109
24-Apr-13Reiterated Deutsche Bank Buy $108 → $115
15-Apr-13Reiterated Barclays Equal Weight $90 → $105
08-Apr-13Reiterated RBC Capital Mkts Outperform $95 → $105
25-Jan-13Upgrade Argus Hold → Buy $96
24-Jan-13Reiterated UBS Buy $96 → $98
12-Sep-12Downgrade Robert W. Baird Outperform → Neutral $84
10-Sep-12Upgrade UBS Neutral → Buy $80 → $96
02-Aug-12Downgrade Argus Buy → Hold
15-Mar-12Resumed Stifel Nicolaus Hold
09-Feb-12Downgrade Oppenheimer Outperform → Perform
20-Aug-14 10:08AM  Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus Zacks
19-Aug-14 04:25PM  Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 Zacks
09:50AM  A New Cannabinoid-based Arthritis Therapy in the Making Accesswire
08:55AM  Amgen parathyroid drug succeeds in late-stage trial (Aug 18) Reuters
08:07AM  Morning Movers: Home Depot Jumps on Big Beat; Aeropostale Climbs on New CEO at Barrons.com
07:07AM  [video] Hot biotech drugs at CNBC
01:55AM  Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company PR Newswire
18-Aug-14 11:21PM  Nasdaq hits highest level since March 2000 at USA TODAY
05:55PM  Amgen thyroid drug succeeds in late-stage trial Reuters
05:17PM  Amgen Announces Positive Top-Line Results From Second Phase 3 Study Of AMG 416 For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease Receiving Hemodialysis PR Newswire
04:10PM  Ligand Up on Multi-Program Captisol Deal with Avion Pharma Zacks
03:35PM  4 Large-Cap Healthcare Stocks To Watch at Investopedia
15-Aug-14 08:03AM  The Zacks Analyst Blog Highlights: Amgen, ANN, Citi Trends, Men's Wearhouse and Kate Spade Zacks
12:00AM  Amgen Market Value Playing Catch-Up to Shares: Chart of the Day at Bloomberg
14-Aug-14 05:39PM  The New Large Cap All Time Highs... Yahoo Finance Blogs
04:25PM  Stocks End With Small Gains; Amgen Shrugs Off Drug Data at Investor's Business Daily
04:20PM  Amgen's FOCUS Study on Multiple Myeloma Drug Kyprolis Fails Zacks
03:41PM  Amgen: Why No One Cares About Kyprolis Trial Failure at Barrons.com
03:10PM  [video] Red hot biotech stocks at CNBC
11:17AM  Trade-Ideas: Amgen (AMGN) Is Today's "Barbarian At The Gate" Stock at TheStreet
10:09AM  US STOCKS-Wall St edges up after Putin comments, Cisco falls Reuters
10:00AM  [video] U.S. Stocks Open Higher Despite Unexpected Rise in Jobless Claims at TheStreet
09:15AM  Lemelson Capital Says Ligand Pharmaceuticals' $225M Debt Issuance Solidifies Company's Insolvency, Substantially Raises Specter of Bankruptcy PR Newswire
09:03AM  Wal-Mart's woes; Kohl's climbs; Cisco cuts jobs Hot Stock Minute
08:03AM  [video] Amgen's cancer drug fails to improve survival rates at CNBC
13-Aug-14 06:31PM  [$$] Amgen Cancer Drug Kyprolis Fails Trial at The Wall Street Journal
06:04PM  Much Ado About Nothing? Amgen Drops in After Hours on Failed Trial, Recall at Barrons.com
05:04PM  After hours buzz: Cisco, NetApp, Amgen and more at CNBC
04:55PM  Amgen recalls syringes of anemia drug Aranesp at MarketWatch
04:55PM  Amgen drug fails to improve survival in multiple myeloma trial Reuters
04:53PM  [$$] Amgen Cancer Drug Kyprolis Fails Trial at The Wall Street Journal
04:34PM  CORRECT: Amgen shares fall after-hours on disappointing trial data at MarketWatch
04:32PM  Amgen Drops in After Hours on Failed Trial, Recall at Barrons.com
04:19PM  Amgen shares fall after-hours on disappointing trial data at MarketWatch
04:12PM  Amgen Issues Voluntary Recall of Aranesp┬« (darbepoetin alfa) (500 mcg) Prefilled Syringes in Several Countries Outside of the United States Due to the Presence of Visible Particulates PR Newswire
04:01PM  Amgen Announces Top-Line Results From Phase 3 Focus Trial Of Kyprolis┬« In Patients With Relapsed And Advanced Refractory Multiple Myeloma PR Newswire
12-Aug-14 01:04PM  AMGEN INC Financials EDGAR Online Financials
11-Aug-14 01:41PM  Amgen rally gets cool reception optionMONSTER
08-Aug-14 10:26AM  Howard Zauberman, the President and CEO of Vision-Sciences, Inc. (VSCI), Interviews with The Wall Street Transcript Wall Street Transcript
07-Aug-14 10:32AM  Ligand Gains on Q2 Earnings Beat, Increases Guidance Zacks
08:38AM  Take Two Interactive, Loews, Amgen, Vertex and Regeneron highlighted as Zacks Bull and Bear of the Day Zacks
06-Aug-14 05:20PM  Congrats on a great quarter now, you're fired at USA TODAY
03:20PM  Congrats on a great quarter now, you're fired at USA TODAY
01:23PM  Celgene: Five Reasons to Be Bullish at Barrons.com
11:00AM  Biotech Stock Roundup: Amgen Plans Job Cuts, Regeneron's Eylea Continues to Impress Zacks
06:00AM  The R&D Hall of Fame: Who makes the cut? at CNBC
06:00AM  The R&D Hall of Fame: Which companies got elected? at CNBC
05-Aug-14 05:21PM  Amgen's Multiple Myeloma Drug Kyprolis Succeeds Zacks
04:06PM  AMGEN INC Files SEC form 10-Q, Quarterly Report EDGAR Online
04-Aug-14 06:58PM  [video] Cramer looks for bright spots in the market at CNBC
04:59PM  Amgen reports positive results from analysis of its blood cancer drug at Los Angeles Times
04:49PM  [video] The Top Ten Stocks for Aug. 4 at Bloomberg
03:50PM  [video] Amgen's Multiple Myeloma Drug Shows Promise in Phase 3 Trial at TheStreet
03:15PM  Why Amgen (AMGN) Stock Is Up Today at TheStreet
01:10PM  Offshore drillers sink after downgrade at Financial Times
01:02PM  Midday movers: Amgen, Groupon, Walt Disney & more at CNBC
12:40PM  Amgen Says Drug Passed Trial; Investors Expected Higher Gains StockTwits
11:34AM  Trial Succeeds, Amgen CEO Doesn't Have To Quit at Forbes
10:56AM  Amgen Cancer Drug Kyprolis Succeeds In Trial at Investor's Business Daily
09:36AM  Mobileye rises for second day; Michael Kors falls at MarketWatch
09:20AM  Morning Movers: Stocks Bounce Back; Kors Cardinal Health Slip; Amgen Gains at Barrons.com
09:11AM  Michael Kors sales sizzle; Amgen blood cancer drug trial a success; Mobileye races ahead again Hot Stock Minute
08:41AM  S&P Down 3% - What's on Sale? Zacks
08:34AM  Amgen reports successful late-stage trial of cancer treatment at MarketWatch
08:25AM  [$$] Amgen Multiple Myeloma Drug Meets Endpoint at The Wall Street Journal
07:56AM  Wal-Mart woos consumers online; Michael Kors puts best foot forward; Stocks set to rebound Hot Stock Minute
07:56AM  McDonald's rough few weeks; Wal-Mart woos consumers online; Is the Obama Adm. friendly to business? Hot Stock Minute
07:49AM  Amgen reports positive trial of multiple myeloma treatment at MarketWatch
07:30AM  Amgen Announces Phase 3 ASPIRE Trial Of Kyprolis┬« In Patients With Relapsed Multiple Myeloma Met Primary Endpoint PR Newswire
01-Aug-14 07:44PM  Express Scripts drops Amgen anemia drugs from formulary Reuters
05:12PM  Express Scripts excludes Amgen drugs from 2015 formulary Reuters
03:41PM  Biotechnology Turns to the Furred and Four-Legged at New York Times
12:01PM  Wall Street Transcript Interview with Charles R. Kummeth, the President and CEO of Bio-Techne (TECH) Wall Street Transcript
10:20AM  Do Layoffs in Biotech Send the Right Message? at 24/7 Wall St.
31-Jul-14 02:46PM  [video] Radius CEO: Osteoporosis Drug on Track Despite Skittish Stock at TheStreet
09:33AM  Stock Market News for July 31, 2014 Zacks
01:08AM  [$$] Drug Firms Buy $67.5 Million Voucher to Speed FDA Review at The Wall Street Journal
12:43AM  [$$] Drug Firms Buy $67.5 Million Voucher to Speed FDA Review at The Wall Street Journal
12:10AM  [$$] Drug Firms Buy $67.5 Million Voucher to Speed FDA Review at The Wall Street Journal
30-Jul-14 10:55PM  [$$] Drug Firms Buy $67.5 Million Voucher to Speed FDA Review at The Wall Street Journal +5.44%
08:43PM  [$$] Drug Firms Buy $67.5 Million Voucher to Speed FDA Review at The Wall Street Journal
07:21PM  [$$] Drug Firms Buy $67.5 Million Voucher to Speed FDA Review at The Wall Street Journal
06:00PM  [video] Cramer's 5 steps of the stock market at CNBC
05:34PM  Small biopharma companies see large gains on a big earnings day at MarketWatch
05:02PM  AMGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
04:42PM  [$$] Amgen Makes the Cut at Barrons.com
02:18PM  Today's Trades: 3 Big Stocks Getting Big Attention at TheStreet
01:42PM  Amgen Price Target Raised by Various Analysts Benzinga
01:21PM  Rising sales and job cut plan boost Amgen at Financial Times
01:08PM  Amgen, Regeneron rise as health-care companies see strong earnings at MarketWatch
11:45AM  Amgen's stock soars to record high on news of planned job cuts at Los Angeles Times
11:20AM  Amgen Restructuring Plan, Q2 Earnings Send Stock Up at Investor's Business Daily
11:05AM  Amgen Pleases the Street -- but Will Layoffs Keep Critics at Bay? at TheStreet
10:50AM  Major markets little changed after economic news AP
10:50AM  Amgen shares hit record on cost-cutting plans at MarketWatch
10:20AM  [video] Stocks Rise at the Open as U.S. Economy Grows Above Estimates at TheStreet
09:59AM  Amgen Surges on News It Will Cut 2,400 Jobs at Bloomberg
09:50AM  [video] The Top Ten Stocks for Wednesday, July 30 at Bloomberg
09:48AM  Cramer: These 2 biotech stocks are going higher at CNBC
09:45AM  Trade-Ideas: Amgen (AMGN) Is Today's New Lifetime High Stock at TheStreet
Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine worldwide. Its principal products include Neulasta, a pegylated protein for the treatment of chemotherapy-induced febrile neutropenia; NEUPOGEN, a recombinant-methionyl human granulocyte colony-stimulating factor for treating the patients with non-myeloid malignancies; and Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis in adult patients. The company's principal products also comprise Aranesp and EPOGEN erythropoiesis-stimulating agents for the treatment of anemia and dialysis; XGEVA and Prolia for the prevention of skeletal-related events and treatment of postmenopausal women with osteoporosis; and Sensipar/Mimpara products for use in the treatment of secondary hyperparathyroidism in CKD patients on dialysis. Its other marketed products include Nplate, a thrombopoietic compound; and Vectibix, a human monoclonal antibody. The company's products in phase 3 clinical trial comprise Evolocumab, a human monoclonal antibody used for the treatment for dyslipidemia; Talimogene Laherparepvec for the treatment of unresected stage IIIB, IIIC, or IV melanoma; and Trebananib for the treatment of ovarian cancer. Its other product in development stage includes Ivabradine, an oral drug for chronic heart failure and stable angina in patients with elevated heart rates. The company markets its products to healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies; consumers; and pharmaceutical wholesale distributors. It has collaborative arrangements with Pfizer Inc.; Glaxo Group Limited; AstraZeneca Plc.; Takeda Pharmaceutical Company Limited; UCB; and Bayer HealthCare Pharmaceuticals Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Harper Sean EEVP, Research & DevelopmentAug 05Sale127.2914,0001,782,12659,503Aug 07 04:22 PM
Dittrich Thomas J.W.VP, Finance & CAOMay 21Option Exercise56.644,130233,91122,719May 22 05:15 PM
Dittrich Thomas J.W.VP, Finance & CAOMay 21Sale112.834,130465,98418,589May 22 05:15 PM
Bradway Robert AChairman, CEO and PresidentMay 12Buy111.7789499,919185,013May 12 08:33 PM
Michael A KellyActing CFOApr 28Sale110.452,065228,07241,041Apr 29 05:48 PM
de Carbonnel FrancoisDirectorMar 06Option Exercise54.4410,000544,35025,364Mar 07 05:23 PM
de Carbonnel FrancoisDirectorMar 06Sale126.691,000126,69018,343Mar 07 05:23 PM
BALTIMORE DAVIDDirectorFeb 26Option Exercise62.555,000312,75031,879Feb 26 08:28 PM
HENDERSON REBECCA MDirectorFeb 13Option Exercise62.4120,0001,248,16025,549Feb 14 04:34 PM
HENDERSON REBECCA MDirectorFeb 13Sale123.5320,0002,470,6805,549Feb 14 04:34 PM
Bradway Robert AChairman, CEO and PresidentFeb 12Option Exercise62.5565,0004,065,750216,040Feb 14 04:19 PM
AMGEN INC10% OwnerDec 17Buy7.00272,1421,904,994541,399Dec 18 06:09 PM
Balachandran MadhavanEVP, OperationsSep 04Option Exercise58.4318,0001,051,74059,133Sep 05 07:33 PM
Balachandran MadhavanEVP, OperationsSep 04Sale112.7618,0002,029,76834,851Sep 05 07:33 PM
BALTIMORE DAVIDDirectorAug 28Sale109.664,582502,46227,789Aug 30 05:36 PM